“The new treatment would combine this antibody with a very potent form of chemotherapy,” said Paul Crispen, MD, an associate professor in the UF Department of Urology. “This antibody drug conjugate could potentially deliver the chemotherapy selectively to areas of cancer to increase efficacy and limit toxicity.”

Southeastern Section of the AUA Virtual 85th Annual Meeting April 23 - 24, 2021 #SESAUA2021

Learn more | Core Lecture: ""Cancer Immunology and Immunotherapy" | Sergei Kusmartsev, PhD Assistant Professor Department of Urology | Tuesday, 2/23/21 | 7:00 am

We are excited to announce Elizabeth Kwenda has been selected as an American Urological Association and Urology Care Foundation Summer Medical Student Fellowship awardee!

Please join us in congratulating Sergei Kusmartsev, PhD, who has recently been invited to serve as guest editor in Frontiers in Immunology, an immunology journal with…

A pledge of $500,000 to support bladder cancer research in the Department of Urology has recently been made by the board members of the 1923 Fund. This gift will go to support a bladder cancer research initiative headed by Sergei Kusmartsev, PhD. The UF Urology research team will…

The basic science laboratory of the division, headed by Dr. Benjamin Canales and Dr. Saeed Khan, has had another stellar year. With continued NIH R01, R03, and K08 funding, they submitted an invited manuscript to Nature Reviews Disease Primers on nephrolithiasis encompassing pathogenesis, surgical treatments, and medical management.